Immune System News and Research

RSS

Vaccine gives HIV patients a long-term boost

A functional cure for HIV-1 seems feasible after research shows that an immunotherapeutic vaccine demonstrated long-term efficacy at reducing viral load when administered to patients in the early stages of disease.

7 Jan 2013

arGEN-X commences ARGX-110 Phase Ib trial to treat cancer

arGEN-X, a biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announced today the initiation of a Phase Ib first-in-man cancer study with ARGX-110, its first SIMPLE Antibody program to enter the clinic in just three years from initiation of discovery.

7 Jan 2013

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.

7 Jan 2013

Study investigates prolonged pathological outcomes of traumatic brain injury

Researchers from the University of South Florida and colleagues at the James A. Haley Veterans' Hospital studying the long-term consequences of traumatic brain injury using rat models, have found that, overtime, TBI results in progressive brain deterioration characterized by elevated inflammation and suppressed cell regeneration.

7 Jan 2013

Study highlights role of Protein S in maintenance of healthy retina

Researchers at the Hebrew University of Jerusalem, in collaboration with researchers at the Salk Institute in California, have found for the first time that a specific protein is essential not only for maintaining a healthy retina in the eye, but also may have implications for understanding and possibly treating other conditions in the immune, reproductive, vascular and nervous systems, as well as in various cancers.

7 Jan 2013

Researchers identify four new genetic regions associated with Behcet's disease

Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.

7 Jan 2013

High vitamin D in pregnancy may increase food allergy risk in children

Study results published in Allergy suggest that supplementing pregnant women with vitamin D may increase their children’s risk for developing food allergy in infancy.

4 Jan 2013

Study reveals large microbial diversity in breast milk

Spanish researchers have traced the bacterial microbiota map in breast milk, which is the main source of nourishment for newborns. The study has revealed a larger microbial diversity than originally thought: more than 700 species.

4 Jan 2013

Report shows how P. gingivalis manipulates body's immune system to disable normal processes

A new research report published in the Journal of Leukocyte Biology shows how the bacteria known for causing gum disease--Porphyromonas gingivalis--manipulates the body's immune system to disable normal processes that would otherwise destroy it. Specifically, the report shows that this pathogen prompts the production of the anti-inflammatory molecule Interleukin-10 (IL-10).

4 Jan 2013

Manipulating T cells with iPSC techniques could help develop effective immune therapies

The human body contains immune cells programmed to fight cancer and viral infections, but they often have short lifespans and are not numerous enough to overcome attacks by particularly aggressive malignancies or invasions.

4 Jan 2013

Nanoparticle researcher to deliver inaugural presentation at next ACS national meeting

A noted researcher in nanomedicine ― preventing, diagnosing and treating disease with particles so small that thousands fit across the width of a human hair ― will deliver the inaugural presentation in "The Kavli Foundation Emerging Leader in Chemistry Lecture" at the next National Meeting of the American Chemical Society (ACS).

4 Jan 2013

Researchers create killer T lymphocytes from iPS cells

Researchers from the RIKEN Research Centre for Allergy and Immunology in Japan report today that they have succeeded for the first time in creating cancer-specific, immune system cells called killer T lymphocytes, from induced pluripotent stem cells (iPS cells).

4 Jan 2013

Neonatal chemokines altered in autistic spectrum patients

A study by scientists has found limited evidence to support a role for proinflammatory chemokines in the pathophysiology of Autism Spectrum Disorders.

3 Jan 2013

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine.

3 Jan 2013

Deimination restores inner retinal visual function in murine demyelinating disease

Demyelinating diseases, such as multiple sclerosis (MS), are frequently associated with the progressive loss of vision. The retinal nerve damage is thought to be caused by immune system-mediated inflammation; however, other demyelinating disorders, such as Pelizaeus-Merzbacher disease, do not involve the immune system, suggesting that there are other causes of retinal nerve damage.

3 Jan 2013

Heart attack patients may benefit from mild to moderate sleep-disordered breathing

People who suffer from breathing disorders such as sleep apnea are usually at higher risk for cardiovascular disease. But an intriguing new study from Technion-Israel Institute of Technology scientists suggests that some heart attack patients with these conditions may actually benefit from mild to moderate sleep-disordered breathing.

3 Jan 2013

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

2 Jan 2013

Immune System News and Research

Vaccine gives HIV patients a long-term boost

arGEN-X commences ARGX-110 Phase Ib trial to treat cancer

Inovio, MVI collaborate to advance malaria vaccine development and new delivery technologies

Study investigates prolonged pathological outcomes of traumatic brain injury

Study highlights role of Protein S in maintenance of healthy retina

Researchers identify four new genetic regions associated with Behcet's disease

High vitamin D in pregnancy may increase food allergy risk in children

Study reveals large microbial diversity in breast milk

Report shows how P. gingivalis manipulates body's immune system to disable normal processes

Manipulating T cells with iPSC techniques could help develop effective immune therapies

Nanoparticle researcher to deliver inaugural presentation at next ACS national meeting

Researchers create killer T lymphocytes from iPS cells

Neonatal chemokines altered in autistic spectrum patients

CXCR5 molecule effectively polices lung tuberculosis and prevents deadly infection

Deimination restores inner retinal visual function in murine demyelinating disease

Heart attack patients may benefit from mild to moderate sleep-disordered breathing

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Insights into tissue-based T cells

Refined mapping finds over 200 Crohn’s Disease genes

Common cholesterol-lowering drug may help protect against cerebral malaria

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News